Difluprednate: more than meets the eye

Area of Science:

• Pharmaceutical Sciences
• Solid-State Chemistry
• Crystallography

Background:

• Difluprednate is an FDA-approved topical corticosteroid for ocular inflammation and pain.
• Understanding its polymorphic forms is crucial for drug formulation and efficacy.
• Previous literature on difluprednate polymorphism has presented conflicting information.

Purpose of the Study:

• To characterize the three known polymorphic crystal forms of difluprednate.
• To elucidate their preparation methods, thermal stability, crystal structures, and stereochemical preferences.
• To provide accurate data for identification and quantification of difluprednate polymorphs.

Main Methods:

• Differential Scanning Calorimetry (DSC) for thermal analysis.
• Single-crystal X-ray diffraction for structural determination.
• Ab-initio X-ray powder diffraction for structural analysis.
• Solution-state Nuclear Magnetic Resonance (NMR) spectroscopy for chemical shift assignment.

Main Results:

• Three distinct difluprednate polymorphs were identified: one hexagonal (P65) and two orthorhombic (P212121).
• Detailed structural, thermal, and stereochemical properties of each polymorph were clarified.
• NMR provided complete (1)H, (13)C, and (19)F chemical shift assignments.
• Selective isolation pathways for each phase were established.

Conclusions:

• This study resolves previous contradictions in difluprednate polymorphism literature.
• Accurate structural and analytical data are provided for precise identification and quantification.
• Rietveld analysis enables accurate quantification of complex difluprednate polymorphic mixtures.